Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

The Pharmaceutical Market: Estonia

Espicom Healthcare Intelligence
September 30, 2009
48 Pages - Pub ID: ESPI2495249
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Search Inside
this Report
Related Reports


Countries covered: Estonia

Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Additional Information

The Estonian healthcare system is currently being transformed from a state-controlled hospital-based system to a decentralised Western European-style model. The healthcare sector has been undergoing extensive restructuring since 2000 when the government announced its major reform plan, the Estonia Health Project 2015. The pharmaceutical industry has also undergone modernisation in recent years, in order to bring domestic standards in line with international norms. This has been a costly process, compounded by weak external demand.

Estonia is one of the ten countries that joined the European Union in 2004, and as a result changes have been made to pharmaceutical legislation, harmonising manufacturing and marketing operations with those in the EU. This region is important to the Estonian pharmaceutical industry, because in 2006, the EU-25 supplied 97.4% of imports, which make up the majority of the market. Reliance on imports should decrease in the future however, as domestic production activity is improving, manufacturers are required to meet GMP standards and multinational presence is increasing.

Related Reports:
Snapshots Hungary Pharmaceuticals 2009
Snapshots Venezuela Pharmaceuticals 2009
Snapshots Spain Pharmaceuticals 2009
Snapshots South Africa Pharmaceuticals 2009
Snapshots Poland Pharmaceuticals 2009
Kenya Pharmaceuticals and Healthcare Report Q1 2010
Australia Pharmaceuticals and Healthcare Report Q1 2010
Nigeria Pharmaceuticals and Healthcare Report Q1 2010
Argentina Pharmaceuticals and Healthcare Report Q1 2010
Poland Pharmaceuticals and Healthcare Report Q1 2010

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/21/2009 - 2